nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Clomifene—CYP19A1—osteoporosis	0.00547	0.521	CrCbGaD
Procaine—Clomifene—ESR1—osteoporosis	0.00504	0.479	CrCbGaD
Procaine—Syncope—Raloxifene—osteoporosis	0.00379	0.00383	CcSEcCtD
Procaine—Agitation—Calcitriol—osteoporosis	0.00377	0.00381	CcSEcCtD
Procaine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00375	0.00379	CcSEcCtD
Procaine—Nausea—Calcium Acetate—osteoporosis	0.00373	0.00377	CcSEcCtD
Procaine—Loss of consciousness—Raloxifene—osteoporosis	0.00372	0.00376	CcSEcCtD
Procaine—Arthralgia—Estropipate—osteoporosis	0.00372	0.00376	CcSEcCtD
Procaine—Anxiety—Estropipate—osteoporosis	0.0037	0.00374	CcSEcCtD
Procaine—Tinnitus—Risedronate—osteoporosis	0.00369	0.00373	CcSEcCtD
Procaine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00362	0.00366	CcSEcCtD
Procaine—Hypertension—Ibandronate—osteoporosis	0.00361	0.00365	CcSEcCtD
Procaine—Arthralgia—Raloxifene—osteoporosis	0.0036	0.00364	CcSEcCtD
Procaine—Arthralgia—Ibandronate—osteoporosis	0.00356	0.0036	CcSEcCtD
Procaine—Oedema—Estropipate—osteoporosis	0.00356	0.0036	CcSEcCtD
Procaine—Anaphylactic shock—Estropipate—osteoporosis	0.00356	0.0036	CcSEcCtD
Procaine—Anxiety—Ibandronate—osteoporosis	0.00355	0.00359	CcSEcCtD
Procaine—Convulsion—Calcitriol—osteoporosis	0.00355	0.00359	CcSEcCtD
Procaine—Hypertension—Calcitriol—osteoporosis	0.00354	0.00357	CcSEcCtD
Procaine—Bradycardia—Zoledronate—osteoporosis	0.0035	0.00354	CcSEcCtD
Procaine—Anxiety—Calcitriol—osteoporosis	0.00348	0.00351	CcSEcCtD
Procaine—Anaphylactic shock—Ibandronate—osteoporosis	0.00342	0.00345	CcSEcCtD
Procaine—Shock—Raloxifene—osteoporosis	0.00339	0.00343	CcSEcCtD
Procaine—Chills—Pamidronate—osteoporosis	0.00338	0.00342	CcSEcCtD
Procaine—Thrombocytopenia—Raloxifene—osteoporosis	0.00338	0.00341	CcSEcCtD
Procaine—Shock—Ibandronate—osteoporosis	0.00336	0.0034	CcSEcCtD
Procaine—Anaphylactic shock—Calcitriol—osteoporosis	0.00334	0.00338	CcSEcCtD
Procaine—Hyperhidrosis—Raloxifene—osteoporosis	0.00334	0.00337	CcSEcCtD
Procaine—Hyperhidrosis—Ibandronate—osteoporosis	0.0033	0.00334	CcSEcCtD
Procaine—Nausea—Ergocalciferol—osteoporosis	0.00329	0.00333	CcSEcCtD
Procaine—Erythema—Pamidronate—osteoporosis	0.00328	0.00331	CcSEcCtD
Procaine—Urticaria—Etidronic acid—osteoporosis	0.00327	0.00331	CcSEcCtD
Procaine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00325	0.00328	CcSEcCtD
Procaine—Angioedema—Ethinyl Estradiol—osteoporosis	0.00323	0.00327	CcSEcCtD
Procaine—Sweating increased—Estradiol—osteoporosis	0.00323	0.00326	CcSEcCtD
Procaine—Tension—Pamidronate—osteoporosis	0.00322	0.00325	CcSEcCtD
Procaine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.0032	0.00323	CcSEcCtD
Procaine—Nervousness—Pamidronate—osteoporosis	0.00318	0.00322	CcSEcCtD
Procaine—Somnolence—Estropipate—osteoporosis	0.00317	0.0032	CcSEcCtD
Procaine—Angioedema—Risedronate—osteoporosis	0.00315	0.00319	CcSEcCtD
Procaine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00314	0.00318	CcSEcCtD
Procaine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00311	0.00315	CcSEcCtD
Procaine—Syncope—Risedronate—osteoporosis	0.00309	0.00313	CcSEcCtD
Procaine—Chills—Zoledronate—osteoporosis	0.00309	0.00312	CcSEcCtD
Procaine—Fatigue—Estropipate—osteoporosis	0.00307	0.0031	CcSEcCtD
Procaine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00305	0.00308	CcSEcCtD
Procaine—Hypersensitivity—Etidronic acid—osteoporosis	0.00303	0.00307	CcSEcCtD
Procaine—Loss of consciousness—Risedronate—osteoporosis	0.00303	0.00306	CcSEcCtD
Procaine—Agitation—Pamidronate—osteoporosis	0.00301	0.00305	CcSEcCtD
Procaine—Anxiety—Ethinyl Estradiol—osteoporosis	0.003	0.00303	CcSEcCtD
Procaine—Angioedema—Pamidronate—osteoporosis	0.003	0.00303	CcSEcCtD
Procaine—Erythema—Zoledronate—osteoporosis	0.003	0.00303	CcSEcCtD
Procaine—Hypertension—Risedronate—osteoporosis	0.00298	0.00301	CcSEcCtD
Procaine—Somnolence—Calcitriol—osteoporosis	0.00297	0.003	CcSEcCtD
Procaine—Fatigue—Ibandronate—osteoporosis	0.00295	0.00298	CcSEcCtD
Procaine—Syncope—Pamidronate—osteoporosis	0.00294	0.00297	CcSEcCtD
Procaine—Arthralgia—Risedronate—osteoporosis	0.00294	0.00297	CcSEcCtD
Procaine—Leukopenia—Pamidronate—osteoporosis	0.00294	0.00297	CcSEcCtD
Procaine—Anxiety—Risedronate—osteoporosis	0.00293	0.00296	CcSEcCtD
Procaine—Pruritus—Etidronic acid—osteoporosis	0.00291	0.00294	CcSEcCtD
Procaine—Neuropathy peripheral—Estradiol—osteoporosis	0.0029	0.00293	CcSEcCtD
Procaine—Oedema—Ethinyl Estradiol—osteoporosis	0.00289	0.00292	CcSEcCtD
Procaine—Erythema—Conjugated Estrogens—osteoporosis	0.00288	0.00291	CcSEcCtD
Procaine—Loss of consciousness—Pamidronate—osteoporosis	0.00288	0.00291	CcSEcCtD
Procaine—Convulsion—Pamidronate—osteoporosis	0.00284	0.00287	CcSEcCtD
Procaine—Hypertension—Pamidronate—osteoporosis	0.00283	0.00286	CcSEcCtD
Procaine—Tension—Conjugated Estrogens—osteoporosis	0.00283	0.00286	CcSEcCtD
Procaine—Urticaria—Estropipate—osteoporosis	0.00283	0.00286	CcSEcCtD
Procaine—Vision blurred—Zoledronate—osteoporosis	0.00282	0.00285	CcSEcCtD
Procaine—Diarrhoea—Etidronic acid—osteoporosis	0.00282	0.00285	CcSEcCtD
Procaine—Body temperature increased—Estropipate—osteoporosis	0.00282	0.00285	CcSEcCtD
Procaine—Tremor—Zoledronate—osteoporosis	0.00281	0.00284	CcSEcCtD
Procaine—Nervousness—Conjugated Estrogens—osteoporosis	0.0028	0.00283	CcSEcCtD
Procaine—Arthralgia—Pamidronate—osteoporosis	0.00279	0.00282	CcSEcCtD
Procaine—Urticaria—Alendronate—osteoporosis	0.00279	0.00282	CcSEcCtD
Procaine—Anxiety—Pamidronate—osteoporosis	0.00278	0.00281	CcSEcCtD
Procaine—Body temperature increased—Alendronate—osteoporosis	0.00277	0.0028	CcSEcCtD
Procaine—Shock—Risedronate—osteoporosis	0.00277	0.0028	CcSEcCtD
Procaine—Agitation—Zoledronate—osteoporosis	0.00275	0.00278	CcSEcCtD
Procaine—Angioedema—Zoledronate—osteoporosis	0.00274	0.00277	CcSEcCtD
Procaine—Body temperature increased—Raloxifene—osteoporosis	0.00273	0.00276	CcSEcCtD
Procaine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00272	0.00275	CcSEcCtD
Procaine—Urticaria—Ibandronate—osteoporosis	0.00271	0.00274	CcSEcCtD
Procaine—Body temperature increased—Ibandronate—osteoporosis	0.0027	0.00273	CcSEcCtD
Procaine—Syncope—Zoledronate—osteoporosis	0.00269	0.00271	CcSEcCtD
Procaine—Leukopenia—Zoledronate—osteoporosis	0.00268	0.00271	CcSEcCtD
Procaine—Oedema—Pamidronate—osteoporosis	0.00268	0.0027	CcSEcCtD
Procaine—Anaphylactic shock—Pamidronate—osteoporosis	0.00268	0.0027	CcSEcCtD
Procaine—Urticaria—Calcitriol—osteoporosis	0.00266	0.00268	CcSEcCtD
Procaine—Body temperature increased—Calcitriol—osteoporosis	0.00264	0.00267	CcSEcCtD
Procaine—Angioedema—Conjugated Estrogens—osteoporosis	0.00264	0.00266	CcSEcCtD
Procaine—Shock—Pamidronate—osteoporosis	0.00263	0.00266	CcSEcCtD
Procaine—Loss of consciousness—Zoledronate—osteoporosis	0.00263	0.00266	CcSEcCtD
Procaine—Hypersensitivity—Estropipate—osteoporosis	0.00262	0.00265	CcSEcCtD
Procaine—Thrombocytopenia—Pamidronate—osteoporosis	0.00262	0.00265	CcSEcCtD
Procaine—Vomiting—Etidronic acid—osteoporosis	0.00262	0.00265	CcSEcCtD
Procaine—Tachycardia—Pamidronate—osteoporosis	0.00261	0.00264	CcSEcCtD
Procaine—Rash—Etidronic acid—osteoporosis	0.0026	0.00262	CcSEcCtD
Procaine—Convulsion—Zoledronate—osteoporosis	0.0026	0.00262	CcSEcCtD
Procaine—Dermatitis—Etidronic acid—osteoporosis	0.00259	0.00262	CcSEcCtD
Procaine—Hyperhidrosis—Pamidronate—osteoporosis	0.00259	0.00261	CcSEcCtD
Procaine—Syncope—Conjugated Estrogens—osteoporosis	0.00259	0.00261	CcSEcCtD
Procaine—Hypertension—Zoledronate—osteoporosis	0.00259	0.00261	CcSEcCtD
Procaine—Hypersensitivity—Alendronate—osteoporosis	0.00258	0.00261	CcSEcCtD
Procaine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00256	0.00259	CcSEcCtD
Procaine—Arthralgia—Zoledronate—osteoporosis	0.00255	0.00258	CcSEcCtD
Procaine—Anxiety—Zoledronate—osteoporosis	0.00254	0.00257	CcSEcCtD
Procaine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00253	0.00256	CcSEcCtD
Procaine—Pruritus—Estropipate—osteoporosis	0.00252	0.00255	CcSEcCtD
Procaine—Hypersensitivity—Ibandronate—osteoporosis	0.00252	0.00254	CcSEcCtD
Procaine—Hypotension—Pamidronate—osteoporosis	0.0025	0.00253	CcSEcCtD
Procaine—Convulsion—Conjugated Estrogens—osteoporosis	0.0025	0.00253	CcSEcCtD
Procaine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00249	0.00252	CcSEcCtD
Procaine—Pruritus—Alendronate—osteoporosis	0.00248	0.00251	CcSEcCtD
Procaine—Tinnitus—Estradiol—osteoporosis	0.00247	0.0025	CcSEcCtD
Procaine—Hypersensitivity—Calcitriol—osteoporosis	0.00246	0.00249	CcSEcCtD
Procaine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00246	0.00248	CcSEcCtD
Procaine—Anxiety—Conjugated Estrogens—osteoporosis	0.00245	0.00247	CcSEcCtD
Procaine—Nausea—Etidronic acid—osteoporosis	0.00245	0.00247	CcSEcCtD
Procaine—Anaphylactic shock—Zoledronate—osteoporosis	0.00244	0.00247	CcSEcCtD
Procaine—Oedema—Zoledronate—osteoporosis	0.00244	0.00247	CcSEcCtD
Procaine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00244	0.00246	CcSEcCtD
Procaine—Diarrhoea—Estropipate—osteoporosis	0.00244	0.00246	CcSEcCtD
Procaine—Fatigue—Risedronate—osteoporosis	0.00243	0.00245	CcSEcCtD
Procaine—Pruritus—Ibandronate—osteoporosis	0.00242	0.00244	CcSEcCtD
Procaine—Shock—Zoledronate—osteoporosis	0.0024	0.00243	CcSEcCtD
Procaine—Diarrhoea—Alendronate—osteoporosis	0.0024	0.00243	CcSEcCtD
Procaine—Thrombocytopenia—Zoledronate—osteoporosis	0.00239	0.00242	CcSEcCtD
Procaine—Tachycardia—Zoledronate—osteoporosis	0.00239	0.00241	CcSEcCtD
Procaine—Chills—Estradiol—osteoporosis	0.00238	0.0024	CcSEcCtD
Procaine—Somnolence—Pamidronate—osteoporosis	0.00238	0.0024	CcSEcCtD
Procaine—Pruritus—Calcitriol—osteoporosis	0.00237	0.00239	CcSEcCtD
Procaine—Hyperhidrosis—Zoledronate—osteoporosis	0.00236	0.00239	CcSEcCtD
Procaine—Diarrhoea—Raloxifene—osteoporosis	0.00236	0.00239	CcSEcCtD
Procaine—Dizziness—Estropipate—osteoporosis	0.00236	0.00238	CcSEcCtD
Procaine—Oedema—Conjugated Estrogens—osteoporosis	0.00235	0.00238	CcSEcCtD
Procaine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00235	0.00238	CcSEcCtD
Procaine—Diarrhoea—Ibandronate—osteoporosis	0.00234	0.00236	CcSEcCtD
Procaine—Dizziness—Alendronate—osteoporosis	0.00232	0.00234	CcSEcCtD
Procaine—Shock—Conjugated Estrogens—osteoporosis	0.00232	0.00234	CcSEcCtD
Procaine—Erythema—Estradiol—osteoporosis	0.00231	0.00233	CcSEcCtD
Procaine—Fatigue—Pamidronate—osteoporosis	0.00231	0.00233	CcSEcCtD
Procaine—Tachycardia—Conjugated Estrogens—osteoporosis	0.0023	0.00232	CcSEcCtD
Procaine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00229	0.00232	CcSEcCtD
Procaine—Diarrhoea—Calcitriol—osteoporosis	0.00229	0.00231	CcSEcCtD
Procaine—Hypotension—Zoledronate—osteoporosis	0.00228	0.00231	CcSEcCtD
Procaine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00228	0.00231	CcSEcCtD
Procaine—Dizziness—Raloxifene—osteoporosis	0.00228	0.00231	CcSEcCtD
Procaine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00228	0.0023	CcSEcCtD
Procaine—Tension—Estradiol—osteoporosis	0.00227	0.00229	CcSEcCtD
Procaine—Vomiting—Estropipate—osteoporosis	0.00226	0.00229	CcSEcCtD
Procaine—Dizziness—Ibandronate—osteoporosis	0.00226	0.00228	CcSEcCtD
Procaine—Rash—Estropipate—osteoporosis	0.00225	0.00227	CcSEcCtD
Procaine—Dermatitis—Estropipate—osteoporosis	0.00224	0.00227	CcSEcCtD
Procaine—Nervousness—Estradiol—osteoporosis	0.00224	0.00227	CcSEcCtD
Procaine—Urticaria—Risedronate—osteoporosis	0.00224	0.00226	CcSEcCtD
Procaine—Vomiting—Alendronate—osteoporosis	0.00223	0.00225	CcSEcCtD
Procaine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00223	0.00225	CcSEcCtD
Procaine—Body temperature increased—Risedronate—osteoporosis	0.00223	0.00225	CcSEcCtD
Procaine—Rash—Alendronate—osteoporosis	0.00221	0.00224	CcSEcCtD
Procaine—Dermatitis—Alendronate—osteoporosis	0.00221	0.00223	CcSEcCtD
Procaine—Hypotension—Conjugated Estrogens—osteoporosis	0.0022	0.00222	CcSEcCtD
Procaine—Vomiting—Raloxifene—osteoporosis	0.00219	0.00222	CcSEcCtD
Procaine—Rash—Raloxifene—osteoporosis	0.00218	0.0022	CcSEcCtD
Procaine—Dermatitis—Raloxifene—osteoporosis	0.00217	0.0022	CcSEcCtD
Procaine—Somnolence—Zoledronate—osteoporosis	0.00217	0.0022	CcSEcCtD
Procaine—Vomiting—Ibandronate—osteoporosis	0.00217	0.00219	CcSEcCtD
Procaine—Tremor—Estradiol—osteoporosis	0.00216	0.00219	CcSEcCtD
Procaine—Rash—Ibandronate—osteoporosis	0.00215	0.00218	CcSEcCtD
Procaine—Dermatitis—Ibandronate—osteoporosis	0.00215	0.00217	CcSEcCtD
Procaine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00214	0.00217	CcSEcCtD
Procaine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00213	0.00215	CcSEcCtD
Procaine—Vomiting—Calcitriol—osteoporosis	0.00213	0.00215	CcSEcCtD
Procaine—Agitation—Estradiol—osteoporosis	0.00212	0.00214	CcSEcCtD
Procaine—Nausea—Estropipate—osteoporosis	0.00212	0.00214	CcSEcCtD
Procaine—Body temperature increased—Pamidronate—osteoporosis	0.00212	0.00214	CcSEcCtD
Procaine—Angioedema—Estradiol—osteoporosis	0.00211	0.00213	CcSEcCtD
Procaine—Rash—Calcitriol—osteoporosis	0.00211	0.00213	CcSEcCtD
Procaine—Fatigue—Zoledronate—osteoporosis	0.00211	0.00213	CcSEcCtD
Procaine—Dermatitis—Calcitriol—osteoporosis	0.00211	0.00213	CcSEcCtD
Procaine—Somnolence—Conjugated Estrogens—osteoporosis	0.00209	0.00211	CcSEcCtD
Procaine—Nausea—Alendronate—osteoporosis	0.00208	0.00211	CcSEcCtD
Procaine—Hypersensitivity—Risedronate—osteoporosis	0.00207	0.0021	CcSEcCtD
Procaine—Syncope—Estradiol—osteoporosis	0.00207	0.00209	CcSEcCtD
Procaine—Nausea—Raloxifene—osteoporosis	0.00205	0.00207	CcSEcCtD
Procaine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00204	0.00206	CcSEcCtD
Procaine—Fatigue—Conjugated Estrogens—osteoporosis	0.00203	0.00205	CcSEcCtD
Procaine—Nausea—Ibandronate—osteoporosis	0.00203	0.00205	CcSEcCtD
Procaine—Loss of consciousness—Estradiol—osteoporosis	0.00203	0.00205	CcSEcCtD
Procaine—Hypertension—Estradiol—osteoporosis	0.00199	0.00201	CcSEcCtD
Procaine—Pruritus—Risedronate—osteoporosis	0.00199	0.00201	CcSEcCtD
Procaine—Nausea—Calcitriol—osteoporosis	0.00199	0.00201	CcSEcCtD
Procaine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00198	0.002	CcSEcCtD
Procaine—Hypersensitivity—Pamidronate—osteoporosis	0.00197	0.00199	CcSEcCtD
Procaine—Arthralgia—Estradiol—osteoporosis	0.00197	0.00199	CcSEcCtD
Procaine—Anxiety—Estradiol—osteoporosis	0.00196	0.00198	CcSEcCtD
Procaine—Urticaria—Zoledronate—osteoporosis	0.00194	0.00196	CcSEcCtD
Procaine—Body temperature increased—Zoledronate—osteoporosis	0.00193	0.00195	CcSEcCtD
Procaine—Diarrhoea—Risedronate—osteoporosis	0.00193	0.00195	CcSEcCtD
Procaine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00191	0.00193	CcSEcCtD
Procaine—Pruritus—Pamidronate—osteoporosis	0.00189	0.00191	CcSEcCtD
Procaine—Oedema—Estradiol—osteoporosis	0.00188	0.0019	CcSEcCtD
Procaine—Anaphylactic shock—Estradiol—osteoporosis	0.00188	0.0019	CcSEcCtD
Procaine—Urticaria—Conjugated Estrogens—osteoporosis	0.00187	0.00189	CcSEcCtD
Procaine—Dizziness—Risedronate—osteoporosis	0.00186	0.00188	CcSEcCtD
Procaine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00186	0.00188	CcSEcCtD
Procaine—Shock—Estradiol—osteoporosis	0.00185	0.00187	CcSEcCtD
Procaine—Tachycardia—Estradiol—osteoporosis	0.00184	0.00186	CcSEcCtD
Procaine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00184	0.00186	CcSEcCtD
Procaine—Diarrhoea—Pamidronate—osteoporosis	0.00183	0.00185	CcSEcCtD
Procaine—Hyperhidrosis—Estradiol—osteoporosis	0.00182	0.00184	CcSEcCtD
Procaine—Rash—Ethinyl Estradiol—osteoporosis	0.00182	0.00184	CcSEcCtD
Procaine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00182	0.00184	CcSEcCtD
Procaine—Hypersensitivity—Zoledronate—osteoporosis	0.0018	0.00182	CcSEcCtD
Procaine—Vomiting—Risedronate—osteoporosis	0.00179	0.00181	CcSEcCtD
Procaine—Rash—Risedronate—osteoporosis	0.00177	0.00179	CcSEcCtD
Procaine—Dermatitis—Risedronate—osteoporosis	0.00177	0.00179	CcSEcCtD
Procaine—Dizziness—Pamidronate—osteoporosis	0.00177	0.00179	CcSEcCtD
Procaine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00173	0.00175	CcSEcCtD
Procaine—Pruritus—Zoledronate—osteoporosis	0.00173	0.00175	CcSEcCtD
Procaine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00172	0.00173	CcSEcCtD
Procaine—Nausea—Ethinyl Estradiol—osteoporosis	0.00172	0.00173	CcSEcCtD
Procaine—Vomiting—Pamidronate—osteoporosis	0.0017	0.00172	CcSEcCtD
Procaine—Rash—Pamidronate—osteoporosis	0.00169	0.00171	CcSEcCtD
Procaine—Dermatitis—Pamidronate—osteoporosis	0.00169	0.0017	CcSEcCtD
Procaine—Somnolence—Estradiol—osteoporosis	0.00167	0.00169	CcSEcCtD
Procaine—Diarrhoea—Zoledronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Procaine—Nausea—Risedronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Procaine—Pruritus—Conjugated Estrogens—osteoporosis	0.00167	0.00168	CcSEcCtD
Procaine—Fatigue—Estradiol—osteoporosis	0.00162	0.00164	CcSEcCtD
Procaine—Dizziness—Zoledronate—osteoporosis	0.00162	0.00163	CcSEcCtD
Procaine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00161	0.00163	CcSEcCtD
Procaine—Nausea—Pamidronate—osteoporosis	0.00159	0.00161	CcSEcCtD
Procaine—Dizziness—Conjugated Estrogens—osteoporosis	0.00156	0.00157	CcSEcCtD
Procaine—Vomiting—Zoledronate—osteoporosis	0.00155	0.00157	CcSEcCtD
Procaine—Rash—Zoledronate—osteoporosis	0.00154	0.00156	CcSEcCtD
Procaine—Dermatitis—Zoledronate—osteoporosis	0.00154	0.00156	CcSEcCtD
Procaine—Vomiting—Conjugated Estrogens—osteoporosis	0.0015	0.00151	CcSEcCtD
Procaine—Urticaria—Estradiol—osteoporosis	0.0015	0.00151	CcSEcCtD
Procaine—Body temperature increased—Estradiol—osteoporosis	0.00149	0.0015	CcSEcCtD
Procaine—Rash—Conjugated Estrogens—osteoporosis	0.00148	0.0015	CcSEcCtD
Procaine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00148	0.0015	CcSEcCtD
Procaine—Nausea—Zoledronate—osteoporosis	0.00145	0.00147	CcSEcCtD
Procaine—Nausea—Conjugated Estrogens—osteoporosis	0.0014	0.00141	CcSEcCtD
Procaine—Hypersensitivity—Estradiol—osteoporosis	0.00139	0.0014	CcSEcCtD
Procaine—Pruritus—Estradiol—osteoporosis	0.00133	0.00135	CcSEcCtD
Procaine—Diarrhoea—Estradiol—osteoporosis	0.00129	0.0013	CcSEcCtD
Procaine—Dizziness—Estradiol—osteoporosis	0.00125	0.00126	CcSEcCtD
Procaine—Vomiting—Estradiol—osteoporosis	0.0012	0.00121	CcSEcCtD
Procaine—Rash—Estradiol—osteoporosis	0.00119	0.0012	CcSEcCtD
Procaine—Dermatitis—Estradiol—osteoporosis	0.00119	0.0012	CcSEcCtD
Procaine—Nausea—Estradiol—osteoporosis	0.00112	0.00113	CcSEcCtD
